Our Mission



Research Topics

Join the Movement

This is a human brain that is blue

Our Story

The ADRD Research Institute is a non-profit organization founded by Lucas Allen, whose grandfather has been living with Alzheimer’s disease for more than 12 years. Lucas has firsthand experience with the disease progression throughout all stages, and he firmly believes that technologies such as artificial intelligence has the power to improve lives for patients and their families.

By observing the progression of the dementia over time, he identified many opportunities to detect the disease. His areas of interest include artificial intelligence, robotics, computer programming and mathematical models for computation. He is currently a high school student at Upper Canada College in Toronto, Canada.


About Our Institute

Early Detection at preclinical stage

Use AI and data driven methods for detection and diagnosis of ADRD before symptoms appear. Research various biomarkers that contribute to cognitive impairment via deep machine learning.

prediction of cognitive trajectories

Use deep machine learning approaches to develop computation models to track cognitive impairment and provide guide for clinical decisions. AI is capable of capturing patterns that would otherwise go unnoticed.

AI enabled caregiving for patients

As the patients have limited communication capabilities, technologies can possibly facilitate the communication between the patient and caregivers. 

Guide for AD Patients at MCI satge

Research on options to slow the progression for patients with Alzheimer’s disease once diagnosed of mild cognitive impairment (MCI). 

Researching How ADRD works

With more technology and AI, we can much better understand how ADRD actually works. By better understanding this, we can come up with many solution for early detection of ADRD as well as technologies to assist patients with dementia.

All Current REsearch Topics

Our Mission & Approach

Alzheimer’s disease and related dementia are usually detected through physical signs such as memory loss and an irregular heartbeat or tremors. We’re working on helping patients with ADRD through innovative technologies such as artificial intelligence. By researching more we can come up with solutions to help patient with ADRD.



Worldwide, around 55 million people have dementia

New cases

There are nearly 10 million new cases every year


A new case of dementia arises every 3 seconds

% of 65+ Americans

One in nine people age 65+ older Americans has Alzheimer’s